Skip to main content

Health condition

Clotting disorder testing

Thrombophilia testing - hunting inherited and acquired clotting tendencies - is useful in far fewer situations than commonly assumed: results rarely change treatment, and testing decisions belong with a haematologist, not a checkbox.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key facts

The essentials at a glance.

The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.

  • What panels cover: factor V Leiden, prothrombin gene mutation, protein C, protein S and antithrombin deficiency, plus antiphospholipid antibodies - the acquired syndrome that genuinely changes management

  • When testing helps: unprovoked clots in the young with strong family histories where results would alter duration decisions, suspected antiphospholipid syndrome, and selected recurrent-miscarriage work-ups

  • When it misleads: testing during acute clots or on anticoagulants distorts results; positive results in low-risk relatives generate anxiety without altering advice

  • Specialist: a consultant haematologist should frame the question first - the clot's circumstances usually inform decisions more than any genetic result

Understanding the condition

What it is and what happens next.

What causes it, how it is diagnosed, and the treatment routes available in the UK.

What it is and how it feels

The intuition that a clot demands a search for its genetic cause is understandable and mostly wrong: management decisions after venous thrombosis - above all, how long to anticoagulate - are driven by whether the clot was provoked or unprovoked, its site and severity, and bleeding risk, and the common inherited variants (factor V Leiden and the prothrombin mutation, carried by several percent of the population) barely move recurrence estimates enough to change those decisions. The exceptions define testing's legitimate territory: antiphospholipid syndrome - an acquired autoimmune thrombophilia whose detection genuinely alters anticoagulant choice and duration and connects to pregnancy complications - and the rarer, stronger natural anticoagulant deficiencies in young patients with heavy family histories, where results can influence duration, family counselling and situational prophylaxis around pregnancy, surgery and hormones.

Diagnosis and treatment routes

Testing well means testing deliberately: not during the acute clot or on anticoagulants (both distort multiple assays - timing is choreographed after treatment decisions, if the results would still matter), with antiphospholipid antibodies requiring confirmation twelve weeks apart, and always preceded by the conversation about what each possible result would and would not change - including the implications of cascade-testing relatives, most of whom, if positive, will simply be advised the same common-sense measures as everyone else: mobility, hydration, risk awareness around long travel, oestrogen decisions and hospitalisation prophylaxis. Framed this way, the consultation frequently concludes that the most informative test was the history all along - and when panels are run, a haematologist's interpretation keeps borderline protein S results, pregnancy effects and assay quirks from becoming lifelong mislabels. In many parts of the UK, routine NHS referrals for this kind of problem currently take 20-45+ weeks, whereas an initial appointment with a private consultant is typically available within around two weeks.

Seeing a specialist

Who to see, and how quickly you can be seen.

The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.

Frequently asked

Common questions about Clotting disorder testing.

Quick, plain-English answers to what people ask us most.

  • What is clotting disorder testing?

    Clotting disorder testing involves a series of blood tests used to investigate whether someone has an increased tendency to form blood clots (thrombophilia) or, conversely, an increased tendency to bleed, depending on the clinical reason for testing. Testing is usually considered after a specific clinical event, such as an unexplained blood clot, recurrent miscarriage, or a strong family history of clotting problems. The specific panel of tests depends on the clinical question being asked.

  • Who should be tested for a clotting disorder?

    Testing is generally considered for people who have had an unprovoked (unexplained) blood clot, particularly at a young age, recurrent blood clots, recurrent pregnancy loss, or a strong family history of clotting disorders. It is not typically recommended as routine screening for everyone, since results can be difficult to interpret without a specific clinical context prompting the testing. Your doctor can advise whether testing is appropriate for your specific situation.

  • What conditions does this testing look for?

    Common conditions tested for include Factor V Leiden and prothrombin gene mutations (inherited clotting tendencies), antiphospholipid syndrome (an autoimmune clotting disorder), and deficiencies in natural anticlotting proteins such as protein C, protein S, or antithrombin. The specific tests chosen depend on the clinical reason for testing and sometimes on ethnicity or family history. Results are usually interpreted alongside the full clinical picture rather than in isolation.

  • When is the best time to have this testing done?

    Timing can matter significantly — some tests are less reliable if done during an acute clotting event, while on certain blood-thinning medications, or during pregnancy, since these can affect results. Your doctor will advise on the most appropriate timing for accurate results, which sometimes means waiting until you've completed a course of anticoagulant treatment or a period of time has passed since an acute event. This is an important practical consideration your doctor will factor in when arranging testing.

  • What happens if a clotting disorder is found?

    If a specific clotting disorder is identified, this can help guide decisions about the duration and type of any future blood-thinning treatment, precautions during pregnancy or before surgery, and sometimes testing of other family members. Not every positive result changes management significantly, and your specialist will explain the practical implications specific to your result. Genetic counselling may be appropriate for certain inherited clotting disorders, particularly regarding family testing.

  • When should I see a specialist?

    If you've had an unexplained blood clot, recurrent pregnancy loss, or a relevant family history, a haematology consultation can help determine appropriate testing and interpret the results in context. NHS haematology referral can take several weeks; a private consultation is typically available within about 2 weeks for earlier assessment.